Cargando…
Assessing the efficacy and safety of hydroxychloroquine as outpatient treatment of COVID-19: a randomized controlled trial
BACKGROUND: Identification of therapies to prevent severe COVID-19 remains a priority. We sought to determine whether hydroxychloroquine treatment for outpatients with SARS-CoV-2 infection could prevent hospitalization, mechanical ventilation or death. METHODS: This randomized controlled trial was c...
Autores principales: | Schwartz, Ilan, Boesen, Mari E., Cerchiaro, Graziela, Doram, Craig, Edwards, Brett D., Ganesh, Aravind, Greenfield, Jamie, Jamieson, Scott, Karnik, Vikram, Kenney, Carol, Lim, Rachel, Menon, Bijoy K., Mponponsuo, Kwadwo, Rathwell, Sarah, Ryckborst, Karla J., Stewart, Breanne, Yaskina, Maryna, Metz, Luanne, Richer, Lawrence, Hill, Michael D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CMA Joule Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248582/ https://www.ncbi.nlm.nih.gov/pubmed/34145052 http://dx.doi.org/10.9778/cmajo.20210069 |
Ejemplares similares
-
Minocycline treatment in clinically isolated syndrome and serum NfL, GFAP, and metalloproteinase levels
por: Camara-Lemarroy, Carlos, et al.
Publicado: (2022) -
755. Clinical Adherence to Latent Tuberculosis Screening Recommendations in Adults with Inflammatory Bowel Disease (IBD) Prior to Biologic Therapy
por: Mponponsuo, Kwadwo, et al.
Publicado: (2018) -
A novel preference-informed complementary trial (PICT) design for clinical trial research influenced by strong patient preferences
por: Ali, Samina, et al.
Publicado: (2021) -
Correction to: A novel preference-informed complementary trial (PICT) design for clinical trial research influenced by strong patient preferences
por: Ali, Samina, et al.
Publicado: (2021) -
Hydroxychloroquine for treatment of non‐hospitalized adults with COVID‐19: A meta‐analysis of individual participant data of randomized trials
por: Mitjà, Oriol, et al.
Publicado: (2023)